Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Accumulated Expenses (2016 - 2024)

Creative Medical Technology Holdings (CELZ) has disclosed Accumulated Expenses for 9 consecutive years, with $39920.0 as the latest value for Q4 2024.

  • On a quarterly basis, Accumulated Expenses changed 0.0% to $39920.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $39920.0, a 0.0% change, with the full-year FY2024 number at $39920.0, changed 0.0% from a year prior.
  • Accumulated Expenses was $39920.0 for Q4 2024 at Creative Medical Technology Holdings, down from $42920.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $159771.0 in Q4 2020 to a low of $24385.0 in Q4 2021.
  • A 5-year average of $65828.5 and a median of $39920.0 in 2022 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: soared 138.33% in 2020, then plummeted 84.74% in 2021.
  • Creative Medical Technology Holdings' Accumulated Expenses stood at $159771.0 in 2020, then tumbled by 84.74% to $24385.0 in 2021, then skyrocketed by 63.71% to $39920.0 in 2022, then changed by 0.0% to $39920.0 in 2023, then changed by 0.0% to $39920.0 in 2024.
  • Per Business Quant, the three most recent readings for CELZ's Accumulated Expenses are $39920.0 (Q4 2024), $42920.0 (Q3 2024), and $39920.0 (Q2 2024).